11 Jun 2019
Follicum raises SEK 56m to finance important steps for the pipeline. A directed share issue strengthens the ownership base. Increased activity for a diabetes project could add important value going forward.
Read the full report (Swedish) here.
We use cookies to provide you with the best possible experience of our website Read more
Managing Partner
Telephone: +49 30 809 33 47-13
@
Telephone: +49 40 300 836-11
Telephone: +49 89 255 49 53-11
Telephone: +49 40 300 836-19
Partner
Telephone: +49 40 300 836-16
Telephone: +49 89 255 49 53-15
Telephone: +49 89 255 49 53-17
Telephone: +46 70 496 18 15
Director
Telephone: +46 73 850 35 59
Telephone: +44 20 80176020
Telephone: +45 4199 8252
Telephone: +45 4199 8251
Telephone: +45 2634 9031
10707 Berlin
Telephone: +49 30 809 334 70
Office Management
Telephone: +49 30 809 33 47-10
Telephone: +49 30 809 33 47-12
Telephone: +49 30 809 33 47-25
Vice President
Telephone: +49 30 809 33 47-20
1253 Copenhagen K
Telephone: +45 3945 0010
20354 Hamburg
Telephone: +49 40 300 83 60
Office Management & Accounting
Telephone: +49 40 300 836 10
PR, Marketing & Business Development Manager
Telephone: +49 40 300 836 18
Telephone: +49 40 300 836-24
London WC2N 6DF
Telephone: +44 20 8017 6020
Associate
Telephone: +44 77 1347-8286
80539 München
Telephone: +49 89 255 495 30
Office Management & HR
Telephone: +49 89 255 495 310
Telephone: +49 89 255 49 53-12
111 45 Stockholm
Telephone: +46 8 684 439 00
Strategic Business Manager
Telephone: +46 73 382 10 82
Telephone: +46 70 246 99 88
Director ECM
Telephone: +46 70 434 85 03
Head of Equity Research
Telephone: +46 76 235 03 20
Senior Equity Analyst
Telephone: +46 70 434 90 03
Associate Equity Analyst
Telephone: +46 73 539 66 99
IT&Telecom Expert
Senior Advisor Life Science
Telephone: +46 73 312 44 90
